Dipeptidyl peptidase IV (DP IV, CD26) in patients with inflammatory bowel disease

Scandinavian Journal of Gastroenterology

Volumn 36, Issue 10, 2001, Pages 1067-1072

  Hildebrandt, M ^a   Rose, M ^a   Ruter J ^a   Salama, A ^a   Monnikes H ^a   Klapp, B F ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

CD26; Dipeptidyl peptidase IV; Disease activity; Inflammatory bowel disease

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; OROSOMUCOID;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENTERITIS; ENZYME ACTIVITY; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ADULT; AGED; ANTIGENS, CD26; ANTIGENS, CD95; COLITIS, ULCERATIVE; CROHN DISEASE; HUMANS; MIDDLE AGED; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTES;

EID: 0034863956     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655201750422675     Document Type: Article

References (27)

1. Mucosal immunoregulation and inflammatory bowel disease: New insights from murine models of inflammation
2. CD26: A surface protease involved in T-cell activation
3. Enhancement of antigen-induced T-cell proliferation by soluble CD26/dipeptidyl peptidase IV
4. Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage
5. Processing by CD26/dipeptidyl-peptidase IV reduces the chemotactic and anti-HIV-1 activity of stromal-cell-derived factor-1 alpha
6. Amino-terminal truncation of chemokines by CD26/dipeptidylpeptidase IV. Conversion of rantes into a potent inhibitor of monocyte chemotaxix and HIV-1-infection
7. Human U937 cell surface peptidase activities: Characterization and degradative effect on tumor necrosis factor-alpha
8. CD26/dipeptidyl-peptidase IV down-regulates the eosinophil chemotactic potency, but not the anti-HIV activity of human eotaxin by affecting its interaction with CC chemokine receptor 3
9. Cell surface characterization of T lymphocytes and allergen-specific T cell clones: Correlation of CD26 expression with T(H1) subsets
10. A guardian angel: The involvement of dipeptidyl peptidase IV in psychoneuroendocrine function, nutrition and immune defence
11. Serum dipeptidyl peptidase IV activity in transplant recipients
12. Inhibition of CD26/dipeptidyl peptidase IV activity in vivo prolongs cardiac allograft survival in rat recipients
13. Development of Crohn's Disease Activity Index
14. Identification of the 110000 Mr glycoprotein isolated from rat liver membrane as dipeptidylaminopeptidase IV
15. Peptidases in human bronchoalveolar lining fluid, macrophages; and epithelial cells: Dipeptidyl (amino)peptidase IV, aminopeptidase N, and dipeptidyl (carboxy)peptidase (angiotensin-converting enzyme)
16. Reduced expression of dipeptidyl peptidase (DPP) IV in peripheral blood T lymphocytes of oral cancer patients
17. Alterations in expression and in serum activity of Dipeptidyl Peptidase IV (DPP IV, CD26) in patients with hyporectic eating disorders
18. Activities of dipeptidyl peptidase II and dipeptidyl peptidase IV in synovial fluid from patients with rheumatoid arthritis and osteoarthritis
19. Activity of dipeptidyl peptidase II and dipeptidyl peptidase IV in human gingiva with chronic marginal periodontitis
20. Expression and functional role of 1F7 (CD26) antigen on peripheral blood and synovial fluid T cells in rheumatoid arthritis patients
21. Dipeptidyl peptidase IV in patients with systemic lupus erythematosus
22. Responsiveness of T lymphocytes from systemic lupus erythematosus to signals provided through CD26 antigen
23. Neuropeptide degrading enzymes in normal and inflamed human synovium
24. Increased population of high fluorescence 1F7 (CD26) antigen on T cells in synovial fluid of patients with rheumatoid arthritis
25. Established and emerging biological activity markers of inflammatory bowel disease
26. Relationships between lower plasma L-tryptophan levels and immune-inflammatory variables in depression
27. Preferential elimination of CD28+ T cells in systemic lupus erythematosus (SLE) and the relation with activation-induced apoptosis